Haendl T, Strobel D, Legal W, Frieser M, Hahn E G, Bernatik T
Medicine 1, University of Erlangen Nuremberg, Erlangen.
Ultraschall Med. 2009 Feb;30(1):58-63. doi: 10.1055/s-2008-1027189.
Grayscale ultrasound has improved the outcome of renal cell cancer (RCC), since most significant RCCs are discovered coincidently during routine abdominal ultrasound examinations. The CT scan is currently the method of choice for further evaluation. The therapeutic approach depends on the results of the CT scan. The purpose of this study was to evaluate whether RCCs would show typical vascularization patterns in contrast-enhanced ultrasonography (CEUS).
We examined 30 patients with solid renal tumors before surgery with CEUS using the microbubble contrast agent SonoVue (Bracco, Italy). All patients had suspected malignant lesions on a CT scan. The examination was performed with an Acuson Sequoia (Siemens, Erlangen, Germany) with a low mechanical index (low MI) using the contrast agent imaging method "contrast pulsed sequencing" (CPS). We looked at the vascularization in the early phase (< 30 s) and the late phase (60 - 120 s). These findings were compared to the histopathological results.
25 (83 %) had an RCC, and two (7 %) patients showed an urothelial carcinoma. Benign tumors were diagnosed in three (10 %) patients. All of them were oncocytomas. In grayscale ultrasound 52 % of the RCCs were hypoechoic, 36 % isoechoic, and 12 % hyperechoic. After the application of the contrast agent, all RCCs showed a chaotic vascularization pattern. In the early phase (< 30 s), 12 tumors showed hyperperfusion, three showed isoperfusion, and nine showed hypoperfusion. During the late phase (60 - 120 s), five tumors showed hyperperfusion, nine showed isoperfusion, and ten showed hypoperfusion. One small cystic tumor did not indicate contrast enhancement at any time.
In our study RCC showed chaotic vascularization in CEUS without typical vascularization patterns.
由于大多数显著的肾细胞癌(RCC)是在常规腹部超声检查时偶然发现的,灰阶超声改善了肾细胞癌的诊疗结果。目前,CT扫描是进一步评估的首选方法。治疗方法取决于CT扫描结果。本研究的目的是评估肾细胞癌在超声造影(CEUS)中是否会显示出典型的血管化模式。
我们使用微泡造影剂声诺维(意大利博莱科公司),通过CEUS对30例患有实性肾肿瘤的患者进行术前检查。所有患者在CT扫描中均怀疑有恶性病变。检查使用西门子公司的ACUSON Sequoia超声诊断仪(德国埃尔朗根),采用低机械指数(低MI),使用造影剂成像方法“对比脉冲序列”(CPS)。我们观察了早期(<30秒)和晚期(60 - 120秒)的血管化情况。将这些结果与组织病理学结果进行比较。
25例(83%)为肾细胞癌,2例(7%)患者为尿路上皮癌。3例(10%)患者被诊断为良性肿瘤,均为嗜酸细胞瘤。在灰阶超声中,52%的肾细胞癌为低回声,36%为等回声,12%为高回声。应用造影剂后,所有肾细胞癌均显示出紊乱的血管化模式。在早期(<30秒),12个肿瘤显示为高灌注,3个显示为等灌注,9个显示为低灌注。在晚期(60 - 120秒),5个肿瘤显示为高灌注,9个显示为等灌注,10个显示为低灌注。1个小囊性肿瘤在任何时候均未显示造影剂增强。
在我们的研究中,肾细胞癌在CEUS中显示出紊乱的血管化,无典型的血管化模式。